Literature DB >> 8742036

Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro.

A J Cunningham1, C A Murray, L A O'Neill, M A Lynch, J J O'Connor.   

Abstract

The effects of the cytokine, interleukin-1 beta (IL-1 beta), and its receptor antagonist IL-1ra, were studied on long-term potentiation in the dentate gyrus of rat hippocampal slices. Field excitatory postsynaptic potentials were recorded extracellularly in the molecular region of the dentate gyrus in response to stimulation of the medial perforant path. Low frequency synaptic transmission was unaffected by IL-1 beta (1 ng/ml), but pre-treatment with IL-1 beta completely blocked induction of long-term potentiation. Co-application of IL-1 beta and IL-1ra (100 ng/ml) attenuated the inhibitory effect of IL-1 beta. In parallel with these findings, we demonstrate that IL-1 beta also inhibited 45Ca influx into the slices. The inhibitory effect of IL-1 beta on induction was mimicked by tumour necrosis factor (TNF; 4.5 ng/ml) and lipopolysaccharide (LPS; 10 micrograms/ml). These results indicate a modulatory role for cytokines in hippocampus and suggest that the inhibitory effect of IL-1 beta on long-term potentiation may relate to its inhibitory effect on calcium channel activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8742036     DOI: 10.1016/0304-3940(95)12252-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  133 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.

Authors:  Justin T Rogers; Josh M Morganti; Adam D Bachstetter; Charles E Hudson; Melinda M Peters; Bethany A Grimmig; Edwin J Weeber; Paula C Bickford; Carmelina Gemma
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 3.  Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition.

Authors:  Ruth M Barrientos; Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Horm Behav       Date:  2012-02-18       Impact factor: 3.587

4.  Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: a role for Toll-like receptor activation.

Authors:  Derek A Costello; Anthony Lyons; Stephanie Denieffe; Tara C Browne; F Fionnuala Cox; Marina A Lynch
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

Review 5.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

6.  Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.

Authors:  Jaewon Lee; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

7.  Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction.

Authors:  Éadaoin W Griffin; Donal T Skelly; Carol L Murray; Colm Cunningham
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

8.  Tumor necrosis factor (TNF) modulates synaptic plasticity in a concentration-dependent manner through intracellular calcium stores.

Authors:  Nicola Maggio; Andreas Vlachos
Journal:  J Mol Med (Berl)       Date:  2018-08-02       Impact factor: 4.599

Review 9.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 10.  Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.

Authors:  James Keblesh; Dehui Hu; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2008-05-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.